|
|||||
|
|
Dimethyl celecoxib as a novel non-cyclooxygenase 2 therapy in the treatment of non-small cell lung cancer |
|
| Authors: | Backhus Leah M Petasis Nicos A Uddin Jasim Schönthal Axel H Bart Robert D Lin Yuanguang Starnes Vaughn A Bremner Ross M |
| Affiliation: | a Department of Cardiothoracic Surgery, Keck School of Medicine, University of Southern California, Los Angeles, Calif b Department of Chemistry, University of Southern California, Los Angeles, Calif c Department of Molecular Microbiology and Immunology, Keck School of Medicine, University of Southern California, Los Angeles, Calif. |
| Abstract: | |
| Keywords: | COX-2, cyclooxygenase 2 DMC, 2,5-dimethyl celecoxib FBS, fetal bovine serum FITC, fluorescein isothiocyanate IL, interleukin MMP, matrix metalloproteinase MTS, 3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium, inner salt NSCLC, non-small cell lung cancer PBS, phosphate-buffered saline PGE2, prostaglandin E2 RPMI, Roswell Park Memorial Institute |
| 本文献已被 ScienceDirect PubMed 等数据库收录！ | |